Financing in Digital Health
Tuesday, December 05, 2017: 11:30 AM - 12:30 PM
With new innovations in digital health come an increased need to both measure cost and cost-effectiveness, and seek sustainable funding mechanisms. First, researchers from Johns Hopkins will present the methodologies and findings from costing and cost-effectiveness analyses of the mCARE program, which uses mobile phones for pregnancy surveillance and scheduled SMS and home visit reminders. Study findings suggest that the mCARE program is highly cost effective when compared to paper systems with a cost per DALY averted of $47 based on the threshold of Bangladesh GNI per capita. Next, experts from UNICEF and the Asian Development Bank will highlight priority digital health investment leveraging a costing tool that demonstrates opportunity costs for efficiency and effectiveness gains linked to health outcomes. They will also share their thinking on which digital health investments can deliver the best value for money, why governments should invest more domestic funding for health IT and how to support governments in catalyzing more domestic funding. Finally, DAI will share important lessons for startups, digital health companies, and early stage innovators to improve their position to receive innovation challenge funds in a competitive market. Key business insights, technology lessons, and social pitch advice will be shared.